FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948010295> ?p ?o ?g. }

• W2948010295 endingPage "680" @default.
• W2948010295 startingPage "680" @default.
• W2948010295 abstract "Physician behavior in response to knowledge of a patient's CYP2C19 clopidogrel metabolizer status is unknown.To investigate the association of mandatory reporting of CYP2C19 pharmacogenomic testing, provided to investigators with no direct recommendations on how to use these results, with changes in P2Y12 inhibitor use, particularly clopidogrel, in the Randomized Trial to Compare the Safety of Rivaroxaban vs Aspirin in Addition to Either Clopidogrel or Ticagrelor in Acute Coronary Syndrome (GEMINI-ACS-1) clinical trial.The GEMINI-ACS-1 trial compared rivaroxaban, 2.5 mg twice daily, with aspirin, 100 mg daily, plus open-label clopidogrel or ticagrelor (provided), in patients with recent acute coronary syndromes (ACS). The trial included 371 clinical centers in 21 countries and 3037 patients with ACS. Data were analyzed between May 2017 and February 2019.Investigators were required to prestipulate their planned response to CYP2C19 metabolizer status. In response to a regulatory mandate, results for all patients were reported to investigators approximately 1 week after randomization.Reasons for switching P2Y12 inhibitors and occurrence of bleeding and ischemic events were collected.Of 3037 patients enrolled (mean [SD] age, 62.8 [9.0] years; 2275 men [74.9%], and 2824 white race/ethnicity [93.0%]), investigators initially treated 1704 (56.1%) with ticagrelor and 1333 (43.9%) with clopidogrel. Investigators prestipulated that they would use CYP2C19 metabolizer status to change P2Y12 inhibitor in 48.5% of genotyped clopidogrel-treated patients (n = 642 of 1324) and 5.5% of genotyped ticagrelor-treated patients (n = 93 of 1692). P2Y12 inhibitor switching for any reason occurred in 197 patients and was more common in patients treated with ticagrelor (146 of 1704 [8.6%]) compared with clopidogrel (51 of 1333 [3.8%]). Of patients initially treated with ticagrelor, only 1 (0.1% overall; 0.7% of all who switched) was switched based on CYP2C19 status. Of patients initially treated with clopidogrel, 23 (1.7% overall,;45.1% of all who switched) were switched owing to metabolizer status. Of 48 patients (3.6%) with reduced metabolizer status treated initially with clopidogrel, 15 (31.3%) were switched based on metabolizer status, including 48.1% (13 of 27) in which switching was prestipulated.Physicians were evenly split on how to respond to knowledge of CYP2C19 metabolizer status in clopidogrel-treated patients. Mandatory provision of this information rarely prompted P2Y12 inhibitor switching overall, including a minority of patients with reduced metabolizer status. These findings highlight the clinical equipoise among physicians regarding use of this information and the reluctance to use information from routine genotyping in the absence of definitive clinical trial data demonstrating the efficacy of this approach.ClinicalTrials.gov identifier: NCT02293395." @default.
• W2948010295 created "2019-06-07" @default.
• W2948010295 creator A5007480001 @default.
• W2948010295 creator A5010466306 @default.
• W2948010295 creator A5014287819 @default.
• W2948010295 creator A5017098029 @default.
• W2948010295 creator A5018212759 @default.
• W2948010295 creator A5027244910 @default.
• W2948010295 creator A5027482892 @default.
• W2948010295 creator A5034203412 @default.
• W2948010295 creator A5034363730 @default.
• W2948010295 creator A5044787928 @default.
• W2948010295 creator A5055866744 @default.
• W2948010295 creator A5063859581 @default.
• W2948010295 creator A5073596004 @default.
• W2948010295 creator A5082493414 @default.
• W2948010295 creator A5088017620 @default.
• W2948010295 date "2019-07-01" @default.
• W2948010295 modified "2023-10-09" @default.
• W2948010295 title "P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes" @default.
• W2948010295 cites W1964551540 @default.
• W2948010295 cites W1985059672 @default.
• W2948010295 cites W2030352776 @default.
• W2948010295 cites W2097803937 @default.
• W2948010295 cites W2119186881 @default.
• W2948010295 cites W2146033517 @default.
• W2948010295 cites W2147761138 @default.
• W2948010295 cites W2154940301 @default.
• W2948010295 cites W2275672421 @default.
• W2948010295 cites W2287540005 @default.
• W2948010295 cites W2513072880 @default.
• W2948010295 cites W2525184273 @default.
• W2948010295 cites W2596358769 @default.
• W2948010295 cites W2766537985 @default.
• W2948010295 cites W2791656192 @default.
• W2948010295 doi "https://doi.org/10.1001/jamacardio.2019.1510" @default.
• W2948010295 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6547088" @default.
• W2948010295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31141104" @default.
• W2948010295 hasPublicationYear "2019" @default.
• W2948010295 type Work @default.
• W2948010295 sameAs 2948010295 @default.
• W2948010295 citedByCount "9" @default.
• W2948010295 countsByYear W29480102952019 @default.
• W2948010295 countsByYear W29480102952020 @default.
• W2948010295 countsByYear W29480102952021 @default.
• W2948010295 countsByYear W29480102952022 @default.
• W2948010295 countsByYear W29480102952023 @default.
• W2948010295 crossrefType "journal-article" @default.
• W2948010295 hasAuthorship W2948010295A5007480001 @default.
• W2948010295 hasAuthorship W2948010295A5010466306 @default.
• W2948010295 hasAuthorship W2948010295A5014287819 @default.
• W2948010295 hasAuthorship W2948010295A5017098029 @default.
• W2948010295 hasAuthorship W2948010295A5018212759 @default.
• W2948010295 hasAuthorship W2948010295A5027244910 @default.
• W2948010295 hasAuthorship W2948010295A5027482892 @default.
• W2948010295 hasAuthorship W2948010295A5034203412 @default.
• W2948010295 hasAuthorship W2948010295A5034363730 @default.
• W2948010295 hasAuthorship W2948010295A5044787928 @default.
• W2948010295 hasAuthorship W2948010295A5055866744 @default.
• W2948010295 hasAuthorship W2948010295A5063859581 @default.
• W2948010295 hasAuthorship W2948010295A5073596004 @default.
• W2948010295 hasAuthorship W2948010295A5082493414 @default.
• W2948010295 hasAuthorship W2948010295A5088017620 @default.
• W2948010295 hasBestOaLocation W29480102951 @default.
• W2948010295 hasConcept C126322002 @default.
• W2948010295 hasConcept C140840227 @default.
• W2948010295 hasConcept C164705383 @default.
• W2948010295 hasConcept C2776301958 @default.
• W2948010295 hasConcept C2777028646 @default.
• W2948010295 hasConcept C2777628954 @default.
• W2948010295 hasConcept C2777698277 @default.
• W2948010295 hasConcept C2777849778 @default.
• W2948010295 hasConcept C2778661090 @default.
• W2948010295 hasConcept C2779161974 @default.
• W2948010295 hasConcept C2780890252 @default.
• W2948010295 hasConcept C49059817 @default.
• W2948010295 hasConcept C500558357 @default.
• W2948010295 hasConcept C526171541 @default.
• W2948010295 hasConcept C535046627 @default.
• W2948010295 hasConcept C62231903 @default.
• W2948010295 hasConcept C71924100 @default.
• W2948010295 hasConceptScore W2948010295C126322002 @default.
• W2948010295 hasConceptScore W2948010295C140840227 @default.
• W2948010295 hasConceptScore W2948010295C164705383 @default.
• W2948010295 hasConceptScore W2948010295C2776301958 @default.
• W2948010295 hasConceptScore W2948010295C2777028646 @default.
• W2948010295 hasConceptScore W2948010295C2777628954 @default.
• W2948010295 hasConceptScore W2948010295C2777698277 @default.
• W2948010295 hasConceptScore W2948010295C2777849778 @default.
• W2948010295 hasConceptScore W2948010295C2778661090 @default.
• W2948010295 hasConceptScore W2948010295C2779161974 @default.
• W2948010295 hasConceptScore W2948010295C2780890252 @default.
• W2948010295 hasConceptScore W2948010295C49059817 @default.
• W2948010295 hasConceptScore W2948010295C500558357 @default.
• W2948010295 hasConceptScore W2948010295C526171541 @default.
• W2948010295 hasConceptScore W2948010295C535046627 @default.
• W2948010295 hasConceptScore W2948010295C62231903 @default.
• W2948010295 hasConceptScore W2948010295C71924100 @default.

• next